Detalles de la búsqueda
1.
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Blood
; 137(11): 1449-1456, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512412
2.
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031.
Pediatr Blood Cancer
; 68(9): e29212, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245210
3.
Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
Cancer
; 124(15): 3210-3219, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29738613
4.
Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 65(12): e27375, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30277639
5.
Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 65(1)2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28802087
6.
A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.
Br J Haematol
; 170(1): 118-22, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25833390
7.
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Br J Haematol
; 185(2): 374-377, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30117142
8.
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
Lancet Oncol
; 14(10): 999-1008, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23890779
9.
Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study.
Neurooncol Adv
; 6(1): vdae035, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596718
10.
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
N Engl J Med
; 363(14): 1313-23, 2010 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20879880
11.
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
N Engl J Med
; 363(14): 1324-34, 2010 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20879881
12.
Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.
J Clin Oncol
; 41(18): 3374-3383, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126770
13.
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
J Clin Oncol
; 41(30): 4724-4728, 2023 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651654
14.
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
J Clin Oncol
; 41(11): 2098-2107, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669140
15.
Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 59(7): 1284-9, 2012 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22847767
16.
Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.
J Pediatr Hematol Oncol
; 34(1): e30-5, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22052170
17.
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report.
Neuro Oncol
; 24(4): 655-664, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347089
18.
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.
Eur J Cancer
; 172: 264-275, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35809374
19.
Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma.
Arch Pathol Lab Med
; 145(12): 1564-1568, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33769463
20.
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.
J Clin Oncol
; 39(36): 4029-4038, 2021 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34652968